Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Nov 10;12(1):19253.
doi: 10.1038/s41598-022-23180-2.

A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis

Affiliations
Clinical Trial

A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis

Jang Woo Ha et al. Sci Rep. .

Abstract

Anti-cyclic citrullinated peptide antibody testing is used to diagnose rheumatoid arthritis and associated with interstitial lung disease in RA. Herein, we investigate the relationship between anti-CCP antibody and ILD in SSc. We performed a retrospective analysis at a tertiary medical center between 2005 and 2019. Patients with SSc, systemic lupus erythematosus, and polymyositis/dermatomyositis (PM/DM) were evaluated for anti-CCP antibody and ILD. Additionally, medical records of SSc patients with ILD were reviewed. SSc patients had the highest anti-CCP antibody positivity rate compared to those with SLE and PM/DM. The incidence of ILD was higher in SSc patients with anti-CCP antibody than in those without. The usual interstitial pneumonia (UIP) incidence was higher in the anti-CCP antibody-positive group than in the anti-CCP antibody-negative group. The DLCO was lower in the anti-CCP antibody-positive group than in the anti-CCP antibody-negative group. On multivariable analysis, factors associated with SSc-ILD were anti-CCP antibody or rheumatoid factor (β coefficient, 2.652 [95% CI 1.472 to 4.776]) and anti-Scl70 antibody (β coefficient, 4.011 [95% CI 2.142 to 7.508]). Anti-CCP antibody may be associated with a higher incidence of ILD in SSc. SSc patients with anti-CCP antibody may have more UIP pattern and lower DLCO.Trial Registration Retrospectively registered.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Representative HRCT images of patients with SSc-ILD. Axial (A) and coronal (B) HRCT images of an anti-CCP antibody-negative patient with SSc-ILD. They show extensive ground-glass opacities and traction bronchiectasis with basal predominance. These findings are typical of a non-specific interstitial pneumonia pattern. Axial (C) and coronal (D) HRCT images of an anti-CCP antibody-positive patient with SSc-ILD. They show predominant lower lobe pulmonary fibrosis and traction bronchiectasis with exuberant honeycombing sign. These findings are consistent with the usual interstitial pneumonia pattern. HRCT: high resolution computed tomography; SSc: systemic sclerosis; ILD: interstitial lung disease.

Similar articles

Cited by

References

    1. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA, Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum Dis. 2013;72(11):1747–1755. - PubMed
    1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum Dis. 2007;66(7):940–944. - PMC - PubMed
    1. Korsten P, Konig MF, Tampe B, Mirsaeidi M. Editorial: Interstitial lung disease in the context of systemic disease: Pathophysiology Treatment and Outcomes. Front. Med. (Lausanne) 2020;7:644075. - PMC - PubMed
    1. Yoo H, Hino T, Han J, Franks TJ, Im Y, Hatabu H, Chung MP, Lee KS. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management. Eur. J. Radiol. Open. 2021;8:100311. - PMC - PubMed
    1. Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ, Han J. Interstitial lung diseases associated with collagen vascular diseases: Radiologic and histopathologic findings. Radiographics. 2002;22(suppl_1):S151–S165. - PubMed

Publication types

MeSH terms